Global Gut Microbiome Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Gut Microbiome Market Research Report 2024
The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.
According to MRAResearch’s new survey, global Gut Microbiome market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gut Microbiome market research.
Key companies engaged in the Gut Microbiome industry include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Gut Microbiome were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gut Microbiome market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gut Microbiome report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Gut Microbiome market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gut Microbiome market research.
Key companies engaged in the Gut Microbiome industry include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Gut Microbiome were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gut Microbiome market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Segment by Application
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gut Microbiome report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source